First Cancer Patient To Receive The BNT116 mRNA Vaccine
A London cancer patient has become the first human to receive the BNT116 mRNA vaccine by BioNTech for lung cancer. The BNT116 trial may redefine how we treat solid tumors using personalized mRNA technology. #BNT116 #BioNTech #CancerVaccine #LungCancer #mRNAtherapy #PersonalizedMedicine #UCLH #NHS #CancerResearch #MedicalBreakthrough